ADAMA Provides Financial Performance Estimation for the Full Year of

2025

TEL AVIV ISRAEL and BEIJING CHINA January 29 2026 – ADAMA Ltd. (the “Company”) (SZSE

000553) today provided an estimate regarding its financial performance for the full year of 2025. The

Company saw further positive impact of its “Fight Forward” strategic transformation plan with improvements

in key financial metrics including positive adjusted net profit and significantly reduced reported net loss.Sales

For the full year of 2025 ADAMA is expecting to report a decline in revenues of approximately 1% to 4% in

USD compared to the full year of 2024. The decline in revenues was generally attributable to lower prices

and the Company’s decisions to optimize its portfolio and geographical presence and to pivot away from

selling some basic chemical products as well as significant declines in Turkey in Q1. Prices remained weak

mainly due to low prices of active ingredients in light of overcapacity as well as a high-interest-rate

environment and low commodity prices which put pressure on distributors and farmers.Adjusted EBITDA and Net Profit

For the full year of 2025 the Company is expecting to report an increase in adjusted EBITDA and in its

margin in comparison to the full year of 2024. Adjusted EBITDA and its margin improved due to an increase

in the gross profit and its margin mainly reflecting the positive impacts of lower costs due to improved

operational efficiency and lower costs of inventory sold more than compensating for lower prices.The Company expects to report an adjusted net profit in the range of USD 4 million to 54 million for the full

year of 2025 compared to a loss of USD 206 million for the full year of 2024. The profit was mainly due to a

higher adjusted operating profit and lower tax and financial expenses.Estimated

Adjusted net profit (loss) Full Year 2025 Full Year 2024

Net profit (loss) attributable to shareholders (USD

4-54(206)

millions)

Earnings per share (USD) 0.0016-0.0231 (0.0885)

Net profit (loss) attributable to shareholders (RMB

25-385(1468)

millions)

Earnings per share (RMB) 0.0107-0.1651 (0.6302)

Adjusted Net profit excludes the impact of transitory non-operational or non-cash items mainly including:

i. Non-cash amortization charges in respect of transfer assets received from Syngenta related to the

2017 ChemChina-Syngenta acquisition;

ii. Non-cash amortization net charges related to intangible assets created as part of the Purchase Price

Allocation (PPA) on acquisitions with no impact on the ongoing performance of the companies

acquired;

1iii. Restructuring and advisory costs incurred as part of the continued implementation of the Fight

Forward transformation plan;

iv. Fixed asset and inventory impairments related to improvement of operational efficiency as part of

the Fight Forward plan;

v. Provision of cleanup and remediation costs by an indirectly wholly owned subsidiary of the Company

for its plant in Israel;

vi. Compensation related to product liability;

vii. Financial expenses including non-cash expenses related to revaluation of put options attributed to

minority stakes in subsidiaries.Reported EBITDA and Net Loss

The Company expects a higher reported EBITDA and its margin and a lower reported net loss (which

includes the impact of the above adjusted items) for the full year of 2025 compared to 2024. This expectation

is mainly due to higher reported operating profit and lower tax expenses despite an increase in reported

financial expenses.Reported net profit (loss) EstimatedFull Year 2025 Full Year 2024

Net profit (loss) attributable to shareholders (USD

(172)-(122)(407)

millions)

Earnings per share (USD) (0.0737)-(0.0522) (0.1749)

Net profit (loss) attributable to shareholders (RMB

(1233)-(873)(2903)

millions)

Earnings per share (RMB) (0.5290)-(0.3746) (1.2461)

The estimated results of the Company are a preliminary estimation of the Company and have not been

audited or reviewed by certified accountants. However the Company and the external auditor have

preliminarily communicated regarding relevant matters of the performance estimation and have no material

disagreement. These estimations may change as a result of the further processing and analysis of the

financial data that the Company will perform for the preparation of its financial statements which are

expected to be released after trading hours on March 26th 2026.Investors are reminded to exercise caution when making investment decisions.##

About ADAMA

ADAMA Ltd. is a global leader in crop protection providing practical solutions to farmers across the world to

combat weeds insects and disease. Our culture empowers ADAMA's people to actively listen to farmers and

ideate from the field. ADAMA's diverse portfolio of existing active ingredients coupled with its leading

formulation capabilities and proprietary formulation technology platforms uniquely position the company to

develop high-quality innovative and sustainable products to address the many challenges farmers and

customers face today. ADAMA serves customers in dozens of countries globally with direct presence in all

top 20 markets. For more information visit us at www.ADAMA.com.

2Contact

Joshua Phillipson Zhujun Wang

Global Investor Relations China Investor Relations

Email: ir@adama.com Email: irchina@adama.com

3